CLVR (Clever Leaves Holdings) FCF Margin % : -29.91% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Clever Leaves Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Clever Leaves Holdings's Free Cash Flow for the three months ended in Dec. 2023 was $-1.39 Mil. Clever Leaves Holdings's Revenue for the three months ended in Dec. 2023 was $4.64 Mil. Therefore, Clever Leaves Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was -29.91%.

As of today, Clever Leaves Holdings's current FCF Yield % is 107,500.00%.

The historical rank and industry rank for Clever Leaves Holdings's FCF Margin % or its related term are showing as below:

CLVR' s FCF Margin % Range Over the Past 10 Years
Min: -66.25 Med: 0 Max: 0
Current: -66.25

CLVR's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.87 vs CLVR: -66.25

Clever Leaves Holdings FCF Margin % Historical Data

The historical data trend for Clever Leaves Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clever Leaves Holdings FCF Margin % Chart

Clever Leaves Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-711.35

-211.49

-283.03

-185.08

-66.25

Clever Leaves Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-103.29	-153.65	-34.75	-60.45	-29.91

Competitive Comparison of Clever Leaves Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Clever Leaves Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clever Leaves Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Clever Leaves Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Clever Leaves Holdings's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Clever Leaves Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Clever Leaves Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-11.539	/	17.417
	=	-66.25 %

Clever Leaves Holdings's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.387	/	4.638
	=	-29.91 %

Clever Leaves Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Clever Leaves Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clever Leaves Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clever Leaves Holdings Inc (OTCPK:CLVR) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bodega 19-B Parque Industrial Tibitoc P.H, Tocancipa, Cundinamarca, Bogota, COL

Website

https://www.cleverleaves.com

Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namely, the Cannabinoid segment which is comprised of the company's cultivation, extraction, and commercialization of cannabinoid products; and the Non-Cannabinoid operating segment which generates maximum revenue and is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.

Executives

Hague Henry R Iii	officer: Chief Financial Officer	489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Andres Fajardo	director, officer: President	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Julian Wilches	officer: Chief Regulatory Officer	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
Gary M Julien	director	ONE LANDMARK SQUARE, 22ND FLOOR, STAMFORD CT 06901
William Muecke	director	C/O CLEVER LEAVES HOLDINGS, 6501 CONGRESS AVE, SUITE 240, BOCA RATON FL 33487
David Kastin	officer: General Counsel	C/O VITAMIN SHOPPE, INC., SECAUCUS NJ 07094
Kyle Detwiler	director, officer: Chief Executive Officer	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017
George J Schultze	10 percent owner	C/O SCHULTZE ASSET MANAGEMENT, LLC, 3000 WESTCHESTER AVENUE, PURCHASE NY 10577
Elisabeth H Demarse	director	CREDITCARDS.COM, 13809 RESEARCH BOULEVARD, SUITE 906, AUSTIN TX 78750
Etienne H. Deffarges	director	ACCRETIVE HEALTH, INC., 401 NORTH MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Schultze Special Purpose Acquisition Sponsor, Llc	10 percent owner	800 WESTCHESTER AVENUE, SUITE 632, RYE BROOK NY 10573
Amit Pandey	officer: Interim CFO	CLEVER LEAVES HOLDINGS INC., 489 FIFTH AVENUE, 27TH FLOOR, NEW YORK NY 10017